AX PHARMACEUTICAL CORP- avanafil powder

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

AVANAFIL (UNII: DR5S136IVO) (AVANAFIL - UNII:DR5S136IVO)

Available from:

AX Pharmaceutical Corp

INN (International Name):

AVANAFIL

Composition:

AVANAFIL 247.5 g in 250 g

Administration route:

NOT APPLICABLE

Authorization status:

Bulk Ingredient For Animal Drug Compounding

Summary of Product characteristics

AX PHARMACEUTICAL CORP- AVANAFIL POWDER
AX PHARMACEUTICAL CORP
----------
AX PHARMACEUTICAL CORP
AX Pharmaceutical Corp
avanafil powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-459
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
AVANAFIL (UNII: DR5S136 IVO) (AVANAFIL - UNII:DR5S136 IVO)
AVANAFIL
247.5 g in 250 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-459 -0 1
250 g in 1 JAR
0 8 /10 /20 17
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
0 8 /10 /20 17
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-459 ) , relabel(6 2157-459 )
Revised: 8/2017